Abstract: Salsolinol (1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; Sal) is structurally similar to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which is supposed to have a role in the development of Parkinson-like syndrome in both human and non-human subjects. In the human brain, the amount of (R)-enantiomer of Sal is much higher than (S )-enantiomer, suggesting that a putative enzyme may participate in the synthesis of (R)-salsolinol, called (R)-salsolinol synthase. In this study, the (R)-salsolinol synthase activity in the condensation of dopamine and acetaldehyde was investigated in the crude extracts from the brains of Sprague Dawley rats. Identification of the enzymatic reaction products and enzyme activity detection were achieved by HPLC-electrochemical detection. The discovery of this enzyme activity in rat's brain indicates the natural existence of (R)-salsolinol synthase in the brains of humans and rats, and it is distributed in most brain regions of rat with higher activity in soluble proteins extracted from striatum and substantia nigra.
Introduction
The pathogenesis of idiopathic Parkinson's disease (PD) remains to be elucidated. Many reports have revealed the involvement of neurotoxins in the deterioration of nigrostriatal dopamine system in PD . Three endogenous alkaloids were proposed as potential candidates of dopaminergic neurotoxins named salsolinol 2, 3, Sal) , tetrahydropapaveroline (THP) derivative (1BnTIQ) and β-carbolines. Sal, in particular, is toxic to dopaminergic neurons and has recently gained much attention due to its structural similarity with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a potent neurotoxin that specifically degenerates the nigrostriatal dopaminergic neurons, resulting in dopamine deficiency in the striatum, and hence the symptoms of Parkinsonism (Quan et al. 2005) . Therefore, Sal may have an influential role directly or indirectly in causing PD.
Sal is a kind of catechol isoquinoline that can be found in brain, cerebrospinal fluid, blood, and urine (Haber et al. 1996) . It can also be detected in some foods and beverages, such as dried banana and port wine, suggesting that consumption of such daily food items can affect Sal level in tissues (Smythe et al. 1985) .
However, the transport of Sal into brain through the blood-brain barrier is excluded (Origitato et al. 1981; Song et al. 2006) , indicating the in situ synthesis of Sal in the brain. Sal has an asymmetric centre at C1 and exists as (R)-and (S )-enantiomers (Deng et al. 1997) . In humans, reports have shown that (R)-enantiomer of Sal can only be detected (Deng et al. 1995) , whereas others indicated that the enantiomer ratio of (R)-/(S )-Sal was approximately 2 (Musshoff et al. 2000) . In previous studies, the concentration of (R)-Sal was found to be higher than the (S )-Sal, depicting the presence of such biosynthetic enzyme in etiology of disease. Figure 1 illustrates two proposed synthetic pathways of Sal from dopamine and acetaldehyde (AcH). The first one produces the racemic mixture of both enantiomers (Robbins et al. 1968; Zhu et al. 2008) , the latter produces (R)-Sal only Rojkovicova et al. 2008) . Accordingly, the surplus of (R)-Sal detected in the human brain may be biosynthesized by this putative enzyme. Numerous publications have proposed the existence of (R)-salsolinol synthase, however, to our knowledge, only one paper has reported the primary purification of the enzyme from human brains, published by Naoi et al. (1996) from Japan. From then on, salsolinol synthase has not been extensively purified and characterized, and it has also not been reported whether this 1184 X. Chen et al. enzyme exists in the other animal brains or not. Hence further research in this field is necessary to explore the mechanism of action and possible role of (R)-salsolinol synthase in the pathogenesis of PD.
In this study we conducted a series of experiments to examine the existence of salsolinol synthase in rat brain. Chiral analysis was done to demonstrate the fact that this enzyme has an enantio-selectivity. Moreover, the distribution of this enzyme in various regions of brain was thoroughly investigated.
Material and methods

Chemicals and substrates
Dopamine hydrochloride (DA), AcH, Sal, sodium 1-heptanesulphonate and HPLC-grade methanol were purchased from Fisher Scientific Canada (Edmonton, Canada). TrisHCl, perchloric acid, ethylene diamine tetraacetic acid (EDTA), sodium metabisulphite, citric acid and pentobarbital sodium were purchased from Sigma. Disodium EDTA was purchased from Sino-American Biotechnology Company. All other chemicals were obtained from the Beijing Chemical reagent Company in China and all of the chemicals used were of analytical grade and organic solvents were of HPLC grade. A Milli-Q water purifying system was utilized to generate 18.2 MΩ deionized water.
Brain dissection
Sprague-Dawley (SD) rats, weighing 200 ± 20 g, were obtained from Central Animal House of Chinese Academy of Medical Sciences. Rats were kept under standard laboratory conditions, at room temperatures and were supplied with food and water. The rats were anesthetized with sodium pentobarbital (64.8 mg/mL, 50 mg/kg) and decapitated (according to institutional protocols). The brains were removed by standard autopsy procedures and cortex, striantum, substantia nigra, and cerebellum were quickly dissected on a cold plate at 4
• C for subsequent investigations (Musshoff et al. 1999 ). All specimens were frozen at −80
Sample preparation
Tissue samples (0.2-0.5 g) were weighed and transferred to centrifugation tubes. The sample were homogenized with an Ultra Turrax in 1 mL of a solution of 50 mM Tris-HCl, adjusted to pH 7.4 with 1 M HCl. Following centrifugation at 100,000×g for 1 h at 4
• C, the supernatant was collected as crude enzyme. Crude enzyme fraction was incubated in 50 mM Tris-HCl (pH 7.4) with 1 mM DA and 1 mM AcH in a total volume of 1 mL De-Eknamkul et al. 1997) . After incubation at 37
• C for 30 min, 20 µL of 1 M perchloric acid containing 1 mM EDTA and sodium metabisulphite was added to stop the reaction. After mixing and centrifugation at 17,000×g for 15 min, the sample was diluted 25 fold and filtered through a 0.22 µm cellulose membranes before storing at −80
HPLC-electrochemical detection apparatus and chromatographic conditions Enzyme activity was assayed using HPLC-electrochemical detection (ECD) (ESA, Chelmsford, MA, USA) as described previously . Briefly, the oxidation voltage of a model 5020 guard cell was 400 mV, 350 mV, 100 mV and −50 mV. Samples were separated on a reversephased Inertosil ODS-C18 column (4.6 (i.d.) × 150 mm), with a mobile phase (pH 4.0) of citric acid (40 mM), Na2HPO4 (20 mM), Na2EDTA (0.3 mM), 5% methanol, and 1.0 mM heptane sulphonic acid at a flow rate of 1.0 mL/min. The quantity of Sal was calculated using a standard curve generated by standard substances. The salsolinol synthase activity was demonstrated by the increment of Sal during per min per mg of protein at 37
• C, and is represented as nmol min −1 mg −1 . The protein was quantified using the Bradford method (Bradford 1976) .
Preliminary purification of salsolinol synthase The crude enzyme fraction was used for preliminary purification. The sample was first presented on a PA-DEAE-02 column (20 (i.d.) × 100 mm) at the rate of 3.0 mL/min. A non-linear gradient elution of eluents A (25 mM Tris-HCl buffer solution and 1 M NaCl solution) and B (25 mM TrisHCl buffer solution, pH 7.4) was used for the separation. The elution programmer was optimized and conducted as follows: over the range from 0.01 min to 5.00 min, 0% A was used, from 5 min to 25 min, 0-60% A was used, 60-90% A was used in the range of 25 min to 45 min, and then 90-100% A was used from 45min to 48min, finally, separation was done for period from 48 min to 53.01 min with 100% A. Detection was accomplished via UV at 280 nm. In total, 53 fractions were collected after every min. The same fractions from each run were combined, lyophilized and detected the salsolinol synthase activity by HPLC-ECD. The active fraction was then applied on Sephacryl S-100 HR (16 mm (i.d.) × 60 cm) which was equilibrated with 25 mM Tris-HCl buffer solution (pH = 7.4) and 0.15 M NaCl at the rate of 0.5 mL/min. Detection was accomplished via UV at 280 nm. In total, 39 fractions (2 mL) were collected after every 4 min, and detected the activity by HPLC-ECD.
HPLC analysis of the enantiomers of Sal
A β-cyclodextrin-bonded column, nucleodex β-OH (4.0 (i.d.) × 200 mm; Macherey-Nagel, Dtiren, Germany) was used to separate the enantiomers of Sal. For the determination of dopamine and Sal enantiomers, coupled columns, a β-cyclodextrin-bonded column connected with a reversephased Inertosil ODS-C18 column in series was employed ). The mobile phase was 100 mM sodium phosphate buffer (pH 3.6) containing 5% methanol at a flow rate of 0.4 mL/min. The voltammograms of authentic standard of (R)-Sal and the corresponding peak in the sample were measured with an HPLC-ECD system. Quantitation was performed by comparison of the peak area of the sample with that of the standard of Sal.
Results
Crude enzyme fractions prepared from the rat brain were incubated with DA and AcH at pH 7.4, the reaction products appeared in the incubation mixture as detected by HPLC-ECD. As shown in Figure 2 , the incubation of the two substrates with rat brain extracts produced a much large amount of Sal ( Fig. 2A, e) , whereas no much Sal was detected in the condensation of substrates by the non-enzymatic Pictet-Spengler reaction ( Fig. 2A, b ) or in the crude extract containing no substrates ( Fig. 2A, a) . Furthermore, a series of controls were used to rule out the possibility of involvement of other factors in the brain extracts that might affect the process. First, we analyzed two groups of single-substrate reactions, one containing DA only, and the other one only containing AcH. No increase of Sal was detected in either groups compared to positive reaction ( Fig. 2A, c,d ), and the endogenous Sal was lower ( Fig. 2A, a) . Quantitation of the Sal is shown in Figure 2B . It should be noted that DA and Ach can produce a small amount of Sal spontaneously, without the presence of enzyme, so it should be subtracted when calculating the enzyme activity. We also attempted to use different measures to deactivate the enzyme, such as heating, treating with strong acid, urea, or organic solvents; the result showed that treatment with perchloric acid was the best method to deactivate the enzyme (data not shown). These results clearly suggested the existence of enzyme activity in the crude protein fractions of rat brain that rapidly catalyzed the condensation of DA and AcH into Sal.
The enzyme was purified from crude enzyme fraction by HPLC using DEAE column and a gel filtration column. Crude fraction was separated first by DEAE column, and the chromatogram was recorded at a wavelength of 280 nm. The result showed that the activity peak was detected between 17 and 21 min. Then, 17 and 21 min fractions were collected and separated by gel filtration chromatography, and salsolinol synthase was eluted from 137 to 153 min. The specific activity of salsolinol synthase after purification was compared with the activity of crude fraction. Figure 3 documents significant increase of the specific activity of salsolinol synthase after purification, when it was purified 8.8-and 115.2-fold, respectively, suggesting the existence of this enzyme (details of the preliminary purification of this enzyme will be published elsewhere). Further researches about purification and characterization are under investigations.
The separation of DA and Sal enantiomers was found to be dependent on the concentration and pH value of the buffer, as well as on the concentration and nature of the organic solvent. An increase in the polarity of the organic solvent (e.g. methanol) enhanced the separation. Na 2 HPO 4 -NaH 2 PO 4 was most effective buffer for the separation of the enantiomers of Sal. The optimal mobile phase selected was 100 mM sodium phosphate buffer (pH 3.6) containing 5% methanol at a flow rate of 0.4 mL/min. The value of the separa- Fig. 3 . The specific activity of salsolinol synthase purified by different methods compared with crude fraction. One was purified by DEAE column chromatography and 53 fractions were collected after every min, the other was purified by gel filtration column chromatography and 39 fractions were collected after every 4 min. The enzyme activity was detected by HPLC-ECD according to the increment of Sal during per min per mg protein in the condition of 37 • C, represented as nmol min −1 mg −1 .
tion factor (α) corresponding to the enantiomers of Sal was 1.30, and it also shows that the racemic mixture of Sal was well separated from each other and from its catecholamine precursor dopamine under the selected conditions with coupled columns (Fig. 4A) . Figure 4B shows that the ratio of (R)-Sal and (S )-Sal produced by non-enzymatic Pictet-Spengler reaction was about 1. However, in enzymatic reaction, (R)-Sal exhibits an approximately 1.49-fold increase compared to the production of (S )-Sal. These results indicated that the surplus (R)-Sal was biosynthesized by (R)-salsolinol synthase, and the two pathways of Sal production co-exist in rat brain.
Salsolinol synthase activity could be detected in all of these regions (Fig. 5) . This result was the same with the distribution of Sal and its metabolites, which can be detected in many areas of the brain. It was reported that the highest concentration of Sal has been detected in the striatum and substantia nigra (Musshoff et al. 1999) . Our result demonstrated that striatum and substantia nigra contained higher activity of salsolinol synthase than other regions. These results suggested that the distribution of Sal does not depend on its substrate, but on the distribution of its synthesizing enzymes. Salsolinol synthase activity was also detected in SH-SY5Y cells (human neuroblastoma) as 2.7 nmol min
which is higher than the activity in rat brain, suggesting the activity of salsolinol synthase in human brain may be higher than in rat brain.
Discussion
We report evidences for the presence of a putative salsolinol synthase in rat brain, which catalyzes the condensation of DA and AcH to (R)-Sal. The activity of salsolinol synthase was detected by HPLC-ECD. Preparation of the crude enzyme fractions with active enzyme activity could be achieved by using 50 mM Tris-HCl, pH 7.4. The crude extracts, after being preliminary purified by DEAE and gel filtration column chromatography, contained higher activity. The formation of Sal was clearly the result of an enzymatic reaction since no high concentration of Sal was observed in the similar incubation mixture containing deactivated enzyme extracts, enzyme extracts containing single-substrate, or non-enzymatic Pictet-Spengler reaction. It is proposed that there are two synthetic pathways for Sal. Our results suggest that both pathways of Sal synthesis co-exist. Non-enzymatic Pictet-Spengler reaction produces both (R)-and (S )-Sal, and an additional enzymatic activity produces (R)-Sal more than 5 . The specific activity of salsolinol synthase in four major regions of rat brain, such as cortex, striatum, substantia nigra, and cerebellum. Activity was detected in a similar way like that in Figure 3 , and the Sal produced by non-enzymatic Pictet-Spengler reaction was subtracted while calculating the enzyme activity.
(S )-Sal. This result is different from earlier research, which showed that only (R)-Sal could be detected in human brain with PD . However, it is similar to the report where the enantiomeric ratio of (R)-/(S )-Sal was approximately 2 (Zhu et al. 2008) . The disagreements in above mentioned findings may be because salsolinol synthase in our research was extracted from the rat brain and the activity of the enzyme in rat brain is lower than the activity in human brain with PD. However, we confirmed that (R)-Sal was much more than (S )-Sal after catalyzed by crude protein fraction, suggesting the existence of (R)-salsolinol synthase. This is the first time that the activity of (R)-salsolinol synthase in rat brain is detected.
We also detected the activities of salsolinol synthase in several brain regions. The highest level of activity was found in the substantia nigra which is in agreement with previous findings describing the distribution of Sal in human brain ). There was no significant correlation between the activity of salsolinol synthase and the levels of DA, which is only present in striatum and substantia nigra. It might be due to the fact that DA exists selectively in the nigrostriatal dopaminergic neurons, while (R)-Sal is distributed uniformly among brain regions. These results suggest that the concentration of (R)-Sal does not depend on its precursor, but on the activity of the synthesizing enzymes.
Further work on salsolinol synthase will include attempts to isolate and characterize the enzyme from rat brains or cell cultures, and to determine its amino acid sequence. It will be of great interest to compare the sequence of salsolinol synthase with other two PictetSpengler-ases, such as strictosidine synthase and norcoclaurine synthase (Luk et al. 2007; Maresh et al. 2008 ). This study is currently under investigation in our laboratory.
